Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress and prospects: gene transfer into embryonic stem cells.

F Yates1, G Q Daley

  • 1Division of Hematology/Oncology, Children's Hospital, Boston, MA 02115, USA.

Gene Therapy
|October 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma.

Leukemia·2016
Same author

Inhibition of P210BCR/ABL Expression in K562 Cells by Electroporation with an Antisense Oligonucleotide.

Leukemia & lymphoma·2016
Same author

Dissecting reprogramming, differentiation and conversion with network biology.

Leukemia supplements·2016
Same author

The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancy.

Leukemia·2015
Same author

The scope of eugenics.

The Eugenics review·2011
Same author

The next million years.

The Eugenics review·2011

Genetically modified human embryonic stem cells (hESCs) offer a path to pure cell populations for treating diseases. Advances in genome editing and cell selection promise unprecedented quality control for gene therapy applications.

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Gene therapy

Background:

  • Human embryonic stem cells (hESCs) provide a potential unlimited source of human tissue.
  • Differentiating hESCs into pure, clinically useful cell populations for treating genetic and degenerative diseases remains a challenge.

Purpose of the Study:

  • To review advances in genome editing and somatic cell nuclear transfer for hESC research.
  • To explore the potential of genetically modified hESCs for gene therapy and regenerative medicine.

Main Methods:

  • Review of existing literature on genome editing tools (e.g., CRISPR-Cas9).
  • Discussion of somatic cell nuclear transfer (SCNT) techniques.
  • Exploration of cell selection and expansion strategies.

Related Experiment Videos

Main Results:

  • Genome editing and SCNT theoretically enable the creation of genetically repaired isogenic cells.
  • Single-cell isolation and expansion offer a novel approach to quality control in cell therapy.
  • Existing mouse ESC tools can be adapted for hESC applications.

Conclusions:

  • Genetically modified hESCs hold significant promise for treating genetic and degenerative diseases.
  • Advanced cell manipulation techniques can enhance the safety and efficacy of gene therapy.
  • Further research applying these tools to hESCs is warranted for clinical translation.